Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCEANS: Niacin ER and Simvastatin in Dyslipidemia
NCT00080275Phase 3Completed
- Sponsor
- Kos Pharmaceuticals, Inc.
- Start
- Mar 2004
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 3, randomised, open-label trial of simvastatin + extended-release niacin in dyslipidemia and hypercholesterolemia (2 arms), sponsored by Kos Pharmaceuticals, Inc. Started Mar 2004; status: completed.
02
Drugs
simvastatin + extended-release niacin
03
Conditions
dyslipidemiahypercholesterolemia
Beyond the preview
Go deeper on NCT00080275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080275.